Fate Therapeutics
Price & Volume
Stats
See more52W Range | $0.66-$5.92 |
Market Cap | $128.3M |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $13.6M |
Revenue Growth (YoY) | 11% |
Gross Profit (12 Mos) | -$104.9M |
Diluted EPS | -$1.64 |
News
See moreYahoo Finance • 14 days ago
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last month
Fate Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
Yahoo Finance • last month
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 2 months ago
Fate Therapeutics to Present at Upcoming Investor Conferences
About
CEO | Dr. Bahram Valamehr M.B.A., Ph.D. |
Address | 12278 Scripps Summit Drive, San Diego, CA, United States, 92131 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 181 |
